Patents by Inventor Daniel N. HAMILTON
Daniel N. HAMILTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240252814Abstract: Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.Type: ApplicationFiled: September 7, 2023Publication date: August 1, 2024Inventors: James Donald Loudin, Daniel N. Hamilton, Manfred Franke, Douglas Michael Ackermann
-
Publication number: 20210370051Abstract: Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.Type: ApplicationFiled: February 1, 2021Publication date: December 2, 2021Inventors: James Donald Loudin, Daniel N. Hamilton, Manfred Franke, Douglas Michael Ackermann
-
Patent number: 10940310Abstract: Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.Type: GrantFiled: March 18, 2019Date of Patent: March 9, 2021Assignee: Oculeve, Inc.Inventors: James Donald Loudin, Daniel N. Hamilton, Manfred Franke, Douglas Michael Ackermann
-
Patent number: 10918864Abstract: Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.Type: GrantFiled: May 2, 2017Date of Patent: February 16, 2021Assignee: Oculeve, Inc.Inventors: Manfred Franke, Diane Michelle Senchyna, Daniel N. Hamilton
-
Patent number: 10610695Abstract: Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.Type: GrantFiled: September 8, 2017Date of Patent: April 7, 2020Assignee: Oculeve, Inc.Inventors: James Donald Loudin, Manfred Franke, Daniel N. Hamilton, Anand Doraiswamy, Douglas Michael Ackermann
-
Publication number: 20200030615Abstract: Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.Type: ApplicationFiled: October 8, 2019Publication date: January 30, 2020Inventors: James Donald Loudin, Manfred Franke, Daniel N. Hamilton, Anand Doraiswamy, Douglas Michael Ackermann
-
Publication number: 20190308009Abstract: Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.Type: ApplicationFiled: March 18, 2019Publication date: October 10, 2019Inventors: James Donald Loudin, Daniel N. Hamilton, Manfred Franke, Douglas Michael Ackermann
-
Patent number: 10252048Abstract: Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.Type: GrantFiled: February 21, 2017Date of Patent: April 9, 2019Assignee: Oculeve, Inc.Inventors: James Donald Loudin, Daniel N. Hamilton, Manfred Franke, Douglas Michael Ackermann
-
Publication number: 20170368359Abstract: Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.Type: ApplicationFiled: September 8, 2017Publication date: December 28, 2017Inventors: James Donald LOUDIN, Manfred FRANKE, Daniel N. HAMILTON, Anand DORAISWAMY, Douglas Michael ACKERMANN
-
Publication number: 20170312521Abstract: Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.Type: ApplicationFiled: May 2, 2017Publication date: November 2, 2017Inventors: Manfred FRANKE, Diane Michelle SENCHYNA, Daniel N. HAMILTON
-
Patent number: 9764150Abstract: Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.Type: GrantFiled: October 22, 2015Date of Patent: September 19, 2017Assignee: Oculeve, Inc.Inventors: James Donald Loudin, Manfred Franke, Daniel N. Hamilton, Anand Doraiswamy, Douglas Michael Ackermann
-
Publication number: 20170239459Abstract: Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.Type: ApplicationFiled: February 21, 2017Publication date: August 24, 2017Inventors: James Donald LOUDIN, Daniel N. HAMILTON, Manfred FRANKE, Douglas Michael ACKERMANN
-
Patent number: 9737702Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.Type: GrantFiled: September 2, 2016Date of Patent: August 22, 2017Assignee: Oculeve, Inc.Inventors: Douglas Michael Ackermann, James Donald Loudin, John Wardle, Jarren Armond Baldwin, Daniel N. Hamilton, Janusz Kuzma
-
Publication number: 20160367795Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.Type: ApplicationFiled: September 2, 2016Publication date: December 22, 2016Inventors: Douglas Michael ACKERMANN, James Donald LOUDIN, John WARDLE, Jarren Armond BALDWIN, Daniel N. HAMILTON, Janusz KUZMA, Christopher William STIVERS, Manfred FRANKE
-
Patent number: 9440065Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.Type: GrantFiled: June 24, 2014Date of Patent: September 13, 2016Assignee: Oculeve, Inc.Inventors: Douglas Michael Ackermann, James Donald Loudin, John Wardle, Jarren Armond Baldwin, Daniel N. Hamilton, Janusz Kuzma, Christopher William Stivers, Manfred Franke
-
Publication number: 20160114172Abstract: Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.Type: ApplicationFiled: October 22, 2015Publication date: April 28, 2016Inventors: James Donald LOUDIN, Manfred FRANKE, Daniel N. HAMILTON, Anand DORAISWAMY, Douglas Michael ACKERMANN
-
Patent number: 8996137Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.Type: GrantFiled: April 18, 2014Date of Patent: March 31, 2015Assignee: Oculeve, Inc.Inventors: Douglas Michael Ackermann, James Donald Loudin, John Wardle, Jarren Armond Baldwin, Daniel N. Hamilton, Janusz Kuzma, Christopher William Stivers
-
Publication number: 20140371812Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.Type: ApplicationFiled: June 24, 2014Publication date: December 18, 2014Inventors: Douglas Michael ACKERMANN, James Donald LOUDIN, John WARDLE, Jarren Armond BALDWIN, Daniel N. HAMILTON, Janusz KUZMA, Christopher William STIVERS, Manfred FRANKE
-
Publication number: 20140316485Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.Type: ApplicationFiled: April 18, 2014Publication date: October 23, 2014Applicant: Oculeve, Inc.Inventors: Douglas Michael ACKERMANN, James Donald LOUDIN, John WARDLE, Jarren Armond BALDWIN, Daniel N. HAMILTON, Janusz KUZMA, Christopher William STIVERS